Health Herald Grenada: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Herald Grenada.

Press releases published on May 4, 2026

May. 4, 2026

Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial

Indeterminate GlobeNewswire

May. 4, 2026

Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial

Indeterminate GlobeNewswire

May. 4, 2026

CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual Meeting

Indeterminate GlobeNewswire

May. 4, 2026

Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026

Indeterminate GlobeNewswire

May. 4, 2026

Recludix Pharma Announces Upcoming Oral Presentations on Preclinical Data for Oral STAT6 Inhibitor REX-8756 and Topical STAT 1/3 Inhibitors at the Society for Investigative Dermatology (SID) Annual Meeting

Indeterminate GlobeNewswire

May. 4, 2026

Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society

Indeterminate GlobeNewswire

May. 4, 2026

Spur Therapeutics Presents Clinical Insights on Bone Disease Impact of FLT201 in Adults with Gaucher Disease Type 1

Indeterminate GlobeNewswire

May. 4, 2026

Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer

Indeterminate GlobeNewswire

May. 4, 2026

4DMT to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

May. 4, 2026

Valitor Presents Preclinical Data Demonstrating Superior Durability with Six-month Treatment Protocol of VLTR-559 to Treat Wet AMD

Indeterminate GlobeNewswire

May. 4, 2026

Nanox Announces Distribution Agreement with NuvioDx to Support Deployment of Nanox.ARC Systems

Indeterminate GlobeNewswire

May. 4, 2026

Bascom Palmer Eye Institute Presents Four Posters on Rose Bengal Photodynamic Antimicrobial Therapy at ARVO 2026, Advancing the Clinical Case for Provectus’s VisiRose Subsidiary and Rose Bengal Sodium in Infectious Keratitis

Indeterminate GlobeNewswire

May. 4, 2026

HealthLynked Launches New Consumer Platform and Multi-Site Digital Ecosystem to Redefine the Front Door to Healthcare

Indeterminate GlobeNewswire

May. 4, 2026

Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton

Indeterminate GlobeNewswire

May. 4, 2026

LENZ Therapeutics to Report First Quarter 2026 Financial Results and Recent Corporate Highlights on May 11, 2026 and Attend Upcoming Investor Conference

Indeterminate GlobeNewswire

May. 4, 2026

Atsena Presents Positive Interim Six-Month Results from Part B of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

Indeterminate GlobeNewswire

May. 4, 2026

After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS

Indeterminate GlobeNewswire

May. 4, 2026

Akebia Therapeutics Announces Vadadustat Post-hoc Win Statistics Analysis Demonstrating Statistically Significant Reduction in Mortality and Hospitalization Composite Endpoint Published in the Journal of American Society of Nephrology

Indeterminate GlobeNewswire

May. 4, 2026

Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth

Indeterminate GlobeNewswire

May. 4, 2026

Senseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 Million

Indeterminate GlobeNewswire